Although complement was promptly activated after viral infection, to confirm the efficacy of an anti-C5aR Ab treatment compared to a sham treatment control, we measured local and systemic inflammation in mouse lungs at day 3 post-infection. This evidence concerns the gene C5AR1 and infection.